ZYMAXID
Country: Israel
Language: English
Source: Ministry of Health
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
GATIFLOXACIN 0.5 %W/V
Available from:
ALLERGAN ISRAEL LTD
ATC code:
S01AX21
Pharmaceutical form:
OPHTHALMIC SOLUTION
Administration route:
OCULAR
Manufactured by:
ALLERGAN INC., USA
Therapeutic group:
GATIFLOXACIN
Therapeutic indications:
Zymaxid is indicated for the treatment of bacterial conjunctivitis caused by susceptible strains of the following organisms: Aerobic Gram- Negative Bacteria : Haemophilus influenzae, Aerobic Gram-positive Bacteria: Staphylococcus aureus, Staphylococcus epidermidis, Streptococcus mitis group*, Streptococcus oralis *, Streptococcus pneumoniae. Efficacy for this organisms was studied in fewer than 10 infections.
Authorization date:
2012-11-01
